Exhibit 23.5
[IMS HEALTH HQ LIMITED LETTERHEAD]
AstraZeneca PLC
Legal & Secretary’s Department
1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge CB2 0AA
England
For the attention of Adrian Kemp
By email & by post
22 November 2016
Dear Ladies and Gentlemen
IMS DATA DISCLOSURE FOR ANNUAL REPORT AND FORM 20-F INFORMATION 2015
In connection with the filing of the accompanying Registration Statement on Form F-3 (the “Form F-3”) of AstraZeneca PLC (“AstraZeneca”), IMS Health hereby authorises AstraZeneca to refer to IMS Health and certain pharmaceutical industry data derived by IMS Health, as identified on the pages included in Exhibit 15.6 to AstraZeneca’s Annual Report and Form 20-F Information for the fiscal year ended December 31, 2015 (the “Annual Report”), which Annual Report is incorporated by reference in the accompanying Form F-3 of AstraZeneca, subject to the same acknowledgements and agreements as set forth in our letter from IMS Health HQ Limited to AstraZeneca PLC, dated 8 March 2016 and included in Exhibit 15.6 to the Annual Report.
Please indicate your agreement to the foregoing by signing in the space indicated below. Our authorisation will not become effective until accepted and agreed by AstraZeneca.
Very truly yours,
/s/James E. Salitan
James E. Salitan
Vice President and Associate General Counsel
QuintilesIMS
For and on behalf of IMS Health HQ Limited
ACCEPTED AND AGREED
This 22nd day of November 2016
AstraZeneca PLC
/s/ Adrian Kemp
Name: Adrian Kemp
Title: Company Secretary
